This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Stocks Renaissance Technologies Is Buying

BALTIMORE ( Stockpickr) -- It's one thing to follow the moves of some of the world's most successful investors -- but how about the smartest? According to the Financial Times, Jim Simons is just that. The founder of hedge fund manager Renaissance Technologies, Simons earned the moniker of world's smartest billionaire while generating legendary returns at its off Wall Street campus.

Renaissance Technologies isn't like most Wall Street firms because it doesn't hire Wall Street types; only scientists need apply. Simons himself holds a Ph.D. in mathematics and was the chairman of Stony Brook University's math department until 1978 when he entered the investing world full time. Today, around a third of Renaissance's employees are Ph.D.s whose expertise ranges from astronomy to physics.

It's a system that's worked well for the firm, which boasts a 2,478% cumulative return since 1999.

Here's a look at some of the new positions Renaissance Technologies added to its portfolio last quarter.

Also on Stockpickr

It's hard to summarize General Electric's (GE) business in a single sentence: From household appliances to jet engines to media networks, this behemoth $150 billion stock is a far cry from the firm Thomas Edison created in the late 1800s. Right now, GE has some interesting prospects for investors who are willing to see past the GE Capital and NBC Universal headlines.

In the fallout from the credit crunch, GE Capital Services continues to be hit hard by high exposure to commercial real estate and weaker elements of consumer credit. But the division's troubles are buffeted by strong diversification across GE's other lines, and a recovering consumer credit market should start applying the brakes to write-offs.

Ultimately, GE's more-exciting brands should regain the limelight in 2010. Renaissance is long the stock, with a new $152.25 million stake in shares added as of the firm's last quarterly filing.

Life science stock Millipore (MIL) is another stock that Renaissance Technologies picked up in the last quarter, in the form of an $81 million stake. Millipore's products are primarily used by scientists in biotech and pharmaceutical companies, academia and research institutions. With the pharmaceutical industry plagued by patent expirations in the coming years, the battle for R&D spending is on -- a battle that Millipore should be a major beneficiary of.

High acquisition and switching costs give Millipore a strong enough competitive advantage that the firm has consistently generated double-digit profit margins. And those factors have ensured that the company scoops up recurring revenues through the sale of consumables used in the research process.

Right now foreign currency risks are high for Millipore's shareholders. Because the company derives nearly 70% of revenue overseas, volatile currency situations in Europe (and a strengthening dollar, for that matter) don't bode well. That said, as the euro starts to stabilize on hopes that PIIGS concerns can be quelled, the opportunity exists for Millipore to get higher prices in the EU once again.

Who Else Owns Millipore?

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,131.97 +100.83 0.59%
S&P 500 1,998.98 +14.85 0.75%
NASDAQ 4,552.7590 +33.8570 0.75%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs